The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma

  • Victor S.M.C. Correa
  • , Nikolaos E. Efstathiou
  • , Dimitrios P. Ntentakis
  • , Zhen Yu
  • , Toshio Narimatsu
  • , Evangelos Gragoudas
  • , Ivana K. Kim
  • , Demetrios G. Vavvas

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Uveal melanoma (UM) is the most common primary intraocular cancer in the adult population. Recent studies suggested that the NLRP3 inflammasome could be a therapeutic target for cutaneous melanoma (CM), but the role of NLRP3 in UM remains unknown. Here, we analyzed the NLRP3-IL-1β axis in 5 UM and 4 CM cell lines. Expression of NLRP3 mRNA in UM and CM was low, and expression in UM was lower than in CM (P < 0.001). NLRP3 protein levels were below detection limit for all cell lines. UM exhibited lower baseline IL-1β secretion than CM, especially when compared to the Hs294t cell line (P < 0.05). Bioinformatic analysis of human tumor samples showed that UM has significantly lower expression of NLRP3 and IL-1β compared with CM. In conclusion, our work shows evidence of extremely low NLRP3 expression and IL-1β secretion by melanoma cells and highlight differences between CM and UM.

Original languageEnglish
Pages (from-to)545-555
Number of pages11
JournalFEBS Open Bio
Volume13
Issue number3
DOIs
Publication statusPublished - 03-2023
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma'. Together they form a unique fingerprint.

Cite this